Firering Strategic Minerals: From explorer to producer. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Hi, can anyone help me with my ignorance. I bought into this in last February's IPO. I am now being asked if I would like to subscribe to more shares @ �2.25. I have flicked through the prospectus and cannot find any sweeteners attached. Can someone explain why I ( or anyone) would wish to subscribe @ �2.25 when I can buy on the open market @ <�2.15?
but disappointing price action. that 28K trade made quite a hit.
Under 200p ? surely all trades under 200 is a dumping exercise apart from what tiny % were picked up during the drop to 175 not so long ago , Any thoughts !
Arix Biosciences http://bit.ly/2tk0Yxn
“LogicBio has huge potential and, alongside its excellent team and investors, we look forward to supporting the company to achieve continued success in this area,” CEO said.
from Directors Buy,s
Read somewhere that Autolus is coming good,+ Verona sp had a bit of a spike 2 weeks ago but has fellback since Im very surprised can still buy @ IPO level, I'm anticipating a mid to long term hold here
A 7p rise today is very welcome, but, apart from the RNS about our CEO presentation, can anyone speculate on the reason(s) for this increase?
Hi Guy,s Thinking of accumulating into a hefty position here as I think the BOD are top class with a successful golden pedigree in the industry The initial drop to 177 in early april, Was this down to normal IPO tail off ? Spread of 7.5 seems a bit harsh , is this normal Have I missed out on a below 190 entry ? Appreciate some feedback ,, Thanks
Arix Bioscience co-leads $45 million Series B investment round for Harpoon Therapeutics http://bit.ly/2qRKrPt
Arix Bioscience on Friday said that its new business group, Iterum, has raised $65 million by closing a Series B investment round. http://bit.ly/2qDoWAg
This is just the beginning for ARIX plc, some echoes of SXX here. A proper, professional BOD who know their business and are getting on with it properly. GLA
better. more, please. in your own time.
Hi all, was going to buy a small amount (c £5k) as a very long term holding for my sip (10 yrs plus) on float but didn't. At the moment anything Woodford seems to be invested in on the biotech side seems to have had a very poor return. With the fall (following allied I assume) I might go back in.
I though the same thing. Didn't expect a huge boost but a 10% rise would've been normal. Anyway, looks like a great team behind this and in a huge sector with so much potential out there. Happy to leave my holding in the bottom drawer for the next few years and come back and check in in 2020.
I would have thought that a large investment by a £15bn company would have given this share a boost! Shows you what I know!
innovation is value, not squeezing more options from an old drug...he says.
CEO “We are delighted to commence trading on the London Stock Exchange" http://bit.ly/2mbhucS
ceo interview...http://video.cnbc.com/gallery/?video=3000595218
yep
the ceo of this comp,was just being interviewed on cnbc tv. it should be on their video archives about 2 hours time.
Good luck everyone.